Drug development

Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.

CRISPR-Focused Companies Take Stock Dive

Shares in various companies using gene editing technologies fell earlier this week, after it was widely reported that CRISPR may raise the risk of cancer in edited cell populations.